Artelo Biosciences Inc. (ARTL)
Market Closed
30 Sep, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
4. 04
-0.03
-0.7371%
$
2M Market Cap
- P/E Ratio
- Div Yield
67,160 Volume
0 Eps
$ 4.07
Previous Close Investors:
Want to track ARTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Artelo Biosciences Inc. (ARTL) Statistics
Valuation metrics
Market Cap 2M
Enterprise value -2.39M
Trailing P/E (ttm) -0.06
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.27
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.48M
Average volume (90 days) 2.13M
Price summary
52-Week low 0.68
52-Week high 19.91
Beta -
50-Day moving average 3.71
200-Day moving average 3.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:9
Last split Date 31 Aug 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.96%
Return on equity -5.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -42.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.93
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3%
Book value per share (mrq) 16.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
